This nationwide survey of US primary care internists and medical specialists evaluates physicians’ attitudes about the US Food and Drug Administration’s drug approval standards and off-label drug marketing.
No takes yet. Share an insight, caveat, or question.
Kesselheim et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: